ProfileGDS4718 / 1556489_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 15% 13% 8% 13% 10% 14% 15% 12% 11% 10% 11% 7% 16% 13% 17% 10% 13% 8% 7% 10% 12% 13% 9% 9% 11% 13% 16% 13% 10% 11% 10% 14% 19% 10% 16% 12% 12% 14% 12% 15% 11% 12% 14% 11% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.977515
GSM549102patient 115, normal, homogenized [OPG study]3.9099113
GSM549104patient 119, normal, homogenized [OPG study]3.698058
GSM549108patient 138, normal, homogenized [OPG study]3.9276513
GSM549119patient 077, normal, homogenized [OPG study]3.7895710
GSM549133patient 032, cancer, homogenized [OPG study]3.8921614
GSM549139patient 042, cancer, homogenized [OPG study]3.9586515
GSM549099patient 107, normal, homogenized [OPG study]3.8629512
GSM549109patient 139, normal, homogenized [OPG study]3.8565911
GSM549110patient 046, normal, homogenized [OPG study]3.7945810
GSM549114patient 063, normal, homogenized [OPG study]3.8025911
GSM549122patient 082, normal, homogenized [OPG study]3.678647
GSM549134patient 033, cancer, homogenized [OPG study]3.9823816
GSM549136patient 036, cancer, homogenized [OPG study]3.8287113
GSM549140patient 044, cancer, homogenized [OPG study]3.9980217
GSM549111patient 047, normal, homogenized [OPG study]3.754110
GSM549113patient 057, normal, homogenized [OPG study]3.8331713
GSM549132patient 031, cancer, homogenized [OPG study]3.699148
GSM549137patient 038, cancer, homogenized [OPG study]3.651537
GSM549142patient 047, cancer, homogenized [OPG study]3.8433910
GSM549100patient 110, normal, homogenized [OPG study]3.8605412
GSM549107patient 135, normal, homogenized [OPG study]3.8676713
GSM549115patient 068, normal, homogenized [OPG study]3.737289
GSM549116patient 072, normal, homogenized [OPG study]3.732259
GSM549120patient 078, normal, homogenized [OPG study]3.8165911
GSM549131patient 030, cancer, homogenized [OPG study]3.8400113
GSM549118patient 074, normal, homogenized [OPG study]4.0184916
GSM549129patient 027, cancer, homogenized [OPG study]3.9125513
GSM549123patient 088, normal, homogenized [OPG study]3.8057510
GSM549124patient 006, cancer, homogenized [OPG study]3.8630211
GSM549126patient 015, cancer, homogenized [OPG study]3.7580310
GSM549128patient 025, cancer, homogenized [OPG study]3.917714
GSM549103patient 117, normal, homogenized [OPG study]4.1630819
GSM549117patient 073, normal, homogenized [OPG study]3.7804310
GSM549138patient 041, cancer, homogenized [OPG study]3.9929516
GSM549141patient 045, cancer, homogenized [OPG study]3.8064812
GSM549130patient 028, cancer, homogenized [OPG study]3.8507512
GSM549101patient 111, normal, homogenized [OPG study]3.9085314
GSM549105patient 128, normal, homogenized [OPG study]3.8706212
GSM549106patient 134, normal, homogenized [OPG study]3.925115
GSM549112patient 048, normal, homogenized [OPG study]3.8121811
GSM549125patient 011, cancer, homogenized [OPG study]3.873412
GSM549127patient 024, cancer, homogenized [OPG study]3.8972514
GSM549135patient 035, cancer, homogenized [OPG study]3.7824211